Published in Nutr Metab (Lond) on February 14, 2012
Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem (2013) 1.27
Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med (2013) 1.16
Novel metabolic markers for the risk of diabetes development in American Indians. Diabetes Care (2014) 0.92
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Nutrients (2015) 0.88
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res (2015) 0.88
Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system. Pharmacol Rev (2014) 0.87
Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. Am J Physiol Endocrinol Metab (2013) 0.86
Flavonoids as dietary regulators of nuclear receptor activity. Food Funct (2013) 0.82
Green Tea Attenuates Oxidative Stress and Downregulates the Expression of Angiotensin II AT(1) Receptor in Renal and Hepatic Tissues of Streptozotocin-Induced Diabetic Rats. Evid Based Complement Alternat Med (2012) 0.80
Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. Curr Med Chem (2015) 0.79
Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis. Nutrients (2014) 0.78
Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases. Curr Genomics (2016) 0.77
Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia. Toxicol Rep (2016) 0.76
Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration? Curr Neuropharmacol (2014) 0.76
Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review. Front Pharmacol (2017) 0.75
Can Tea Extracts Exert a Protective Effect Against Diabetes by Reducing Oxidative Stress and Decreasing Glucotoxicity in Pancreatic β-Cells? Diabetes Metab J (2015) 0.75
The Natural Occurring Compounds Targeting Endoplasmic Reticulum Stress. Evid Based Complement Alternat Med (2016) 0.75
Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice. Front Physiol (2016) 0.75
Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in db/db Mice. Diabetes (2017) 0.75
Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems. Biomed Res Int (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (2004) 19.08
Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes (2004) 4.73
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia (2007) 4.30
Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest (2008) 4.30
Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr (1997) 3.40
Tea and cancer. J Natl Cancer Inst (1993) 3.31
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia (2007) 2.48
Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology (2000) 1.72
Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) (2005) 1.71
Antimicrobial properties of tea (Camellia sinensis L.). Antimicrob Agents Chemother (1995) 1.69
Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem (2002) 1.56
Tea enhances insulin activity. J Agric Food Chem (2002) 1.43
Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr (2006) 1.42
Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol (2004) 1.41
Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (-)-epicatechin. Life Sci (1982) 1.34
Effects of flavonoids on insulin secretion and 45Ca2+ handling in rat islets of Langerhans. J Endocrinol (1985) 1.31
Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med (2003) 1.21
Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr (2004) 1.21
Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes (1998) 1.07
Tea consumption and cancer. World Rev Nutr Diet (1996) 1.01
Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res (2003) 1.00
Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med (2003) 0.95
Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion. Biochem J (2002) 0.95
Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. J Biol Chem (1997) 0.93
Effects of epicatechin on rat islets of Langerhans. Diabetes (1984) 0.91
Insulin like activity in (-) epicatechin. Acta Diabetol Lat (1990) 0.89
Pancreatic beta-cell regeneration in rats by (-)-epicatechin. Lancet (1981) 0.88
Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line. Cell Biol Toxicol (2009) 0.87
The lack of effectiveness of (-)-epicatechin against alloxan induced diabetes in Wistar rats. Life Sci (1983) 0.85
Antioxidative galloyl esters as enzyme inhibitors of p-hydroxybenzoate hydroxylase. FEBS Lett (2000) 0.81
Assessment of the antidiabetic activity of epicatechin in streptozotocin-diabetic and spontaneously diabetic BB/E rats. Biosci Rep (1985) 0.77
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab (2004) 3.65
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature (2012) 2.83
Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature (2004) 2.73
Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol (2006) 2.17
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism. Regul Pept (2005) 1.56
Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. J Immunol (2008) 1.31
Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats. Clin Sci (Lond) (2012) 1.19
Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res (2012) 1.05
Ethanol acutely stimulates islet blood flow, amplifies insulin secretion, and induces hypoglycemia via nitric oxide and vagally mediated mechanisms. Endocrinology (2007) 0.99
Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways. J Mol Endocrinol (2013) 0.97
Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells. J Gastroenterol (2012) 0.93
Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol (2012) 0.91
A busy cell--endoplasmic reticulum stress in the pancreatic beta-cell. Mol Cell Endocrinol (2007) 0.90
Angiogenesis-independent cardioprotection in FGF-1 transgenic mice. Cardiovasc Res (2002) 0.89
Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction. Clin Sci (Lond) (2005) 0.88
Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats. Clin Sci (Lond) (2007) 0.87
Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity. Diabetes Metab Res Rev (2009) 0.86
Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome. Diabetol Metab Syndr (2014) 0.86
Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease. Am J Physiol Endocrinol Metab (2004) 0.86
Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond) (2006) 0.85
BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner. Am J Physiol Cell Physiol (2008) 0.84
Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion. Am J Physiol Cell Physiol (2006) 0.84
Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression. BMC Complement Altern Med (2011) 0.84
Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells. Biochem Biophys Res Commun (2012) 0.84
Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate. J Neurosci Res (2011) 0.83
Global expression profiling of glucose-regulated genes in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats. J Mol Endocrinol (2007) 0.83
Intrauterine death, fetal malformation, and delayed pregnancy in Ljungan virus-infected mice. Birth Defects Res B Dev Reprod Toxicol (2006) 0.82
Ljungan virus present in intrauterine fetal death diagnosed by both immunohistochemistry and PCR. Birth Defects Res A Clin Mol Teratol (2009) 0.82
Thapsigargin down-regulates protein levels of GRP78/BiP in INS-1E cells. J Cell Biochem (2012) 0.82
Skeletal muscle ouabain binding sites are reduced in rats with chronic heart failure. J Appl Physiol (1985) (2002) 0.81
Disruption of serine/threonine protein phosphatase 5 (PP5:PPP5c) in mice reveals a novel role for PP5 in the regulation of ultraviolet light-induced phosphorylation of serine/threonine protein kinase Chk1 (CHEK1). J Biol Chem (2011) 0.81
Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats. Regul Pept (2012) 0.80
Fetal death persists through recurrent pregnancies in mice following Ljungan virus infection. Birth Defects Res B Dev Reprod Toxicol (2008) 0.80
Pioglitazone acutely influences glucose-sensitive insulin secretion in normal and diabetic human islets. Biochem Biophys Res Commun (2006) 0.80
Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochem Biophys Res Commun (2006) 0.79
Glutamate inhibits protein phosphatases and promotes insulin exocytosis in pancreatic beta-cells. Biochem Biophys Res Commun (2005) 0.79
GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu. J Neurochem (2013) 0.79
The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic rats. Neuropeptides (2012) 0.78
Growth hormone signaling in pancreatic beta-cells--calcium handling regulated by growth hormone. Mol Cell Endocrinol (2008) 0.77
Inhibition of palmitate-induced GADD34 expression augments apoptosis in mouse insulinoma cells (MIN6). Cell Biochem Funct (2014) 0.76
Evidence for paracrine/autocrine regulation of GLP-1-producing cells. Am J Physiol Cell Physiol (2013) 0.76
Comment on "Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma". J Immunol (2009) 0.75
Estimating cardiovascular disease risk in diabetes. Lancet (2006) 0.75
Inositol hexakisphosphate and sulfonylureas regulate beta-cell protein phosphatases. Biochem Biophys Res Commun (2004) 0.75
Glycerol kinase deficiency in adult hypoglycemic acidemia. N Engl J Med (2011) 0.75
Editorial foreword to MCE special issue on "Endocrine aspects of type II diabetes mellitus". Mol Cell Endocrinol (2008) 0.75
[The Swedish Transport Agency's regulations and general guidelines: More opinions than science for patients with type 1 diabetes]. Lakartidningen (2013) 0.75
[How exactly are the activities of the HSAN quality-assured?]. Lakartidningen (2003) 0.75
[Glycerol kinase deficiency with debut of symptoms in adult age. Unusual cause of coma, metabolic acidosis, hypoglycemia and hypothermia]. Lakartidningen (2010) 0.75
Gender-specific regulation of pancreatic islet blood flow, insulin levels and glycaemia in spontaneously diabetic Goto-Kakizaki rats. Clin Sci (Lond) (2008) 0.75